Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × Oxaliplatin × Clear all

NCT00398320 2017-03-01

Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

Phase 2 Completed

40 enrolled 9 charts

Neuroendocrine Tumors